Your browser doesn't support javascript.
loading
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation.
Alonso-Peña, Marta; Espinosa-Escudero, Ricardo; Hermanns, Heike M; Briz, Oscar; Herranz, Jose M; Garcia-Ruiz, Carmen; Fernandez-Checa, Jose C; Juamperez, Javier; Avila, Matias; Argemi, Josepmaria; Bataller, Ramon; Crespo, Javier; Monte, Maria J; Geier, Andreas; Herraez, Elisa; Marin, Jose J G.
Affiliation
  • Alonso-Peña M; Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, 37007 Salamanca, Spain.
  • Espinosa-Escudero R; Gastroenterology and Hepatology Department, Clinical and Translational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, 39008 Santander, Spain.
  • Hermanns HM; Division of Hepatology, Würzburg University Hospital, Medical Clinic II, 97080 Würzburg, Germany.
  • Briz O; Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, 37007 Salamanca, Spain.
  • Herranz JM; Division of Hepatology, Würzburg University Hospital, Medical Clinic II, 97080 Würzburg, Germany.
  • Garcia-Ruiz C; Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, 37007 Salamanca, Spain.
  • Fernandez-Checa JC; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain.
  • Juamperez J; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain.
  • Avila M; Hepatology Program, Liver Unit, Instituto de Investigación de Navarra (IdisNA), Clínica Universidad de Navarra and Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, 31008 Pamplona, Spain.
  • Argemi J; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain.
  • Bataller R; Institute of Biomedical Research of Barcelona (IIBB), Centro Superior de Investigaciones Científicas (CSIC), 08036 Barcelona, Spain.
  • Crespo J; Center for ALPD, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
  • Monte MJ; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Institute of Health, 28029 Madrid, Spain.
  • Geier A; Institute of Biomedical Research of Barcelona (IIBB), Centro Superior de Investigaciones Científicas (CSIC), 08036 Barcelona, Spain.
  • Herraez E; Center for ALPD, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
  • Marin JJG; Pediatric Hepatology and Liver Transplantation Unit, Vall d'Hebron University Hospital (HVH), Universitat Autónoma de Barcelona, 08035 Barcelona, Spain.
Cells ; 11(24)2022 12 09.
Article in En | MEDLINE | ID: mdl-36552746
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Bile Acids and Salts / Hepatitis Limits: Humans Language: En Journal: Cells Year: 2022 Type: Article Affiliation country: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Bile Acids and Salts / Hepatitis Limits: Humans Language: En Journal: Cells Year: 2022 Type: Article Affiliation country: Spain